期刊文献+

直径在2 cm以下非小细胞肺癌淋巴结清扫的临床分析 被引量:6

Clincal research on Surgical treatment for non-small cell lung cancer of diameter less than 2 cm
原文传递
导出
摘要 目的 探讨直径2 cm以下非小细胞肺癌手术切除及淋巴结清扫的方法.方法 收集2004年4月至2007年3月郑州大学第一附属医院192例经高分辨CT确定瘤体最大直径在2 cm以下的非小细胞肺癌术前临床资料、术中所见和快速病理,分析选择合理的手术切除和纵隔淋巴结清扫范围.结果 瘤体直径在1 cm以下、无纵隔淋巴结转移和无胸膜受侵,对患者生存率的影响差异有统计学意义(P<0.01).肿瘤位于肺上叶,51.7%(61/118)发生同侧肺门和纵隔淋巴结转移,28.8%(38/192)发生隆凸下淋巴结转移;腺癌、鳞癌纵隔淋巴结转移发生率为32.2%和15.4%(P=0.0012),腺癌发生纵隔淋巴结转移的风险是鳞癌的1.97倍(OR值为1.97).结论 直径2 cm以下的非小细胞肺癌手术切除时无论瘤体大小,只要患者的心肺功能等许可,应行包括隆突下淋巴结在内的区域纵隔淋巴结清扫,精准合理的纵隔淋巴结清扫可明显提高早期非小细胞肺癌的生存率. Objective To discuss the model of reasonable dissection extent of mediastinal lymph nodes in non-small cell lung cancer of diameter less than 2 cm. Method A study was carried on the clincal data of 192 patients with NSCLC of diameter less than 2 cm undergoing curative resection and mediastinal lymph nodes dissection, According to the size of tumor and the pathology quick report. Results The survival rates of patient was statistically significant difference ( P 〈 0. 01 ) , prognostic factors included diameter of tumor,lymph node metastasis and visceral pleura invasion; 51.7% mediastinal lymph node metastasis of superior lobe tumor, 28.8% transferingto surcarinal node; the mediastinal lymph node metastasic rate of adenocarcinom was32. 2% ,and squamous cell carcinom was 15.4% ( P = 0. 0012 ). Conclusion If the patient's cardiopulmonary function permitting, regardless of the size of focus, Regional mediastinal lymph nodal and surcarinal lymph nodal dissection should be routinely performed on patients with non-small cell lung cancer of diameter less than 2 cm, and improve survival rate.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第31期2502-2504,共3页 National Medical Journal of China
基金 河南省科技厅重点科技攻关项目(102102310410)
关键词 非小细胞肺 淋巴结切除术 预后 Carcinoma, non-small-cell lung Lymph node excision Prognosis
  • 相关文献

参考文献9

  • 1Rusch VW.High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung.J Thorac Cardiovasc Surg,2002,124:221-222.
  • 2Keller SM,Adak S,Wagner H,et al.Mediastinal lymph node dissection improves survival in patients with stages Ⅱ and Ⅲ a non-small cell lung cancer.Eastern Cooperative Oncology Group.Ann Thorac Surg,2000,70:358-365.
  • 3Inoue M,Minami M,Shiono H,et al.Clinicopathologic study of resected,peripheral,small-sized,non-small cell lung cancer tumors of 2 cm or less in diameter:pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.J Thorac Cardiovasc Surg,2006,131:988-993.
  • 4Matsuguma H,Yokoi K,Anraku M,et al.Proportion of groundglass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung:A predictor of lymph node metastasis.J Thorac Cardiovasc Surg,2002,124:278-284.
  • 5Fernando HC,Santos RS,Benfield JR,et al.Lobar and sublobar resection with and without brachytherapy for small stage IA nonsmall cell lung cancer.J Thorac Cardiovasc Surg,2005,129:261-267.
  • 6Takizawa T,Terashima M,Koike T,et al.Lymph node metastasis in small peripheral adenocarcinoma of the lung.J Thorac Cardiovasc Surg,1998,116:276-280.
  • 7Bunn PA Jr.Early-stage non-small-cell lung cancer:current perspectives in combined-modality therapy.Clin Lung Cancer,2004,6:85-98.
  • 8Cerfolio RJ,Bryant AS,Eloubeidi MA.Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative:a prospective study.Chest,2006,130:1791-1795.
  • 9王洲,殷洪年,张林,等.淋巴结廓清程度对CⅠa期肺癌预后影响的价值评价.中国肺癌杂志,2002,12:57-58.

同被引文献46

  • 1黄国俊,毛友生,张德超.局部晚期非小细胞肺癌侵及纵隔器官扩大手术治疗的评价[J].中华肿瘤杂志,2005,27(1):59-61. 被引量:19
  • 2潘铁成,郑智,李军,汤应雄,潘友民,魏翔,陈涛,张霓.肺鳞癌、腺癌肿瘤大小与淋巴结转移关系的临床研究[J].中国肺癌杂志,2006,9(3):267-269. 被引量:13
  • 3Riquet M, Arame A, Foucauh C, et al. Prognostic classifications of lymph node involvement in lung cancer and current International As- sociation for the Study of Lung Cancer descriptive classification in zones [ J ]. Interact Cardiovasc Thorac Surg,2010,11 : 260 - 264.
  • 4Flieder DB, Port JL, Korst R J, et al. Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer[ J]. Chest, 2005128:2304-2308.
  • 5Wisnivesky JP, Yankelevitz D, Henschke CI. Stage of lung cancer in relation to its size : part 2. Evidence [ J ]. Chest,2005,127 : 1136- 1139.
  • 6Darling GE, Allen MS, Decker PA, et al. Randomized trial of me- diastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with NO or N1 ( I ess than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial [ J ]. J Thorae Cm'diovasc Surg,2011,141:6624570.
  • 7王烽;田锋;佟玉筠.PET-CT在周围型非小细胞肺癌N分期及淋巴结清扫中的价值[J]中华临床医师杂志(电子版),2013(02):609-612.
  • 8Li S,Zheng Q,Ma Y. Implications of false negative and false posi-tive diagnosis in lymph node staging of NSCLC by means of (18) F-FDG PET/CTD[J].PLoS One,2013,(10):78552.
  • 9Yoshizawa K,Sasaki Y,Abe Y. Chylothorax in a patient with ad-vanced gastric cancer and mediastinal lymph node metastasis causing thoracic duct obstruction[J].Nihon Shokakibyo Gakkai Zasshi,2013,(11):1943-1949.
  • 10Ito M,Yamashita Y,Tsutani Y. Classifications of N2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes[J].Clin Lung Cancer,2013,(06):651-657.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部